Two cases of sternectomy for bone metastasis due to aggressive variants of thyroid papillary carcinoma  by Luna-Ortiz, Kuauhyama et al.
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INTRODUCTION:  There  are  only  few  cases  reported  about  the  role  of  surgery  in  the  presence  of  single  or
multiple  bulky  bone  metastases.  The  literature  about  treatment  for  bulky  sternal  metastases  is  scarce.
PRESENTATION OF  CASE:  We  present  two patients  treated  surgically  for metastatic  thyroid  lesions.  Case  1  is
a  female  with  tumor  of the  thyroid  right  lobe,  mediastinal  extension  and  multiple  pulmonary  metastases.
Bony  inﬁltration  was  observed  in  the  sternum  and  ribs.  Case  2 is a female  with  a lesion  in  the  cervical
region  of  the thyroid  left lobe  and  increase  in  volume  on  the upper  sternal  manubrium.
DISCUSSION: Patients  with  well-differentiated  thyroid  cancer  may  present  with  extracervical  metastasis
in  5–10%  of  cases  at diagnosis.  Bone  metastases  occur  in  0.4%  of cases  of  papillary  carcinoma.  Managementuality of life
hyroid  pathology
remains  controversial.  There  are  only  isolated  cases  reported  in  the  literature  of  the role  surgery  plays  in
the  presence  of  single  or multiple  bulky  bone  metastases.  The  basis  for  initial  surgical  approach  is  keeping
in  mind  that  the surgical  procedure  is palliative  in order  to achieve  optimal  hypothetical  ablation  as  a
result  of reduced  tumor  volume.
CONCLUSION: Surgery  is  the  elective  treatment  and  can be  performed  safely  and  with  adequate  results,
allowing  proper  optimization  of  the  dose  of 131I for ablative  therapy.
gical  © 2012 Sur
. Introduction
Thyroid cancer is the most common tumor of the endocrine sys-
em and has the most rapid annual increment (4%) of all tumors. The
rognosis of patients with differentiated thyroid cancer is excel-
ent and 10-year survival is >90%.1 However, survival is lower with
oorly differentiated tumors, even in those tumors considered as
ntermediate such as insular tumors, which in Mexico, represent
.5–7%.2 Dissemination of thyroid cancer is primarily via regional
ymph nodes and metastatic pulmonary disease may  develop,
ollowed by bone involvement.3 Only isolated cases have been
eported in the literature describing surgical treatment in bulky
ternal metastases. Management remains controversial; therefore,
e report our experience with two patients.
. Case 1A  Mexican 30-year-old female who presented in August 2010
ith progressively growing tumor in the anterior neck, asso-
iated with occasional dyspnea and dysphagia. Initial physical
∗ Corresponding author at: Avenida San Fernando No. 22, Colonia Sección XVI,
.P.  14080, México DF, Mexico. Tel.: +52 55 5628 0400.
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examination revealed a tumor dependent of the right lobe of the
thyroid gland (5 × 4 cm), which was  soft, adherent to deep planes
and without palpable lymph nodes. In the upper sternal region,
there was  a soft, ﬁxed tumor (∼4 cm). Initial computed tomogra-
phy (CT) scan demonstrated a tumor of the right lobe of the thyroid
gland (6 × 4 cm)  with mediastinal extension and multiple bilateral
lung metastases. Bone inﬁltration was  also observed in the right
sternum and ribs5–7 as well as a solid lesion below the middle third
of the left kidney (∼28 mm in diameter), which was initially consid-
ered to be metastatic. Fine needle aspiration biopsy of the sternal
lesion was  performed, with histopathologic report of follicular neo-
plasm. During a ﬁrst surgical intervention, the patient underwent
total thyroidectomy, partial sternectomy, and partial resection of
the ﬁfth, sixth and seventh right ribs. Eight days later, the patient
underwent left partial nephrectomy. She was discharged 4 days
later with a satisfactory evolution. Pathological study for the thy-
roid tumor reported poorly differentiated, insular-type carcinoma
(80%) associated with conventional papillary carcinoma lined with
tall cells (20%), located in the lower pole of the right lobe. There was
vascular and lymphatic permeation and extension to perithyroid
soft tissues. Sternal lesion was compatible with poorly differenti-
Open access under CC BY-NC-ND license.ated, insular-type papillary carcinoma with soft tissue invasion and
lymphatic permeation. Bony margins were free of neoplasm. The
ribs were also found to have metastatic disease. However, the lesion
found in the left kidney corresponded to a classic angiomyolipoma,
NC-ND license. 
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aig. 1. A 30 years old female patient where CT demonstrates the following: (A) Ster
f  the left kidney suspicious of visceral metastasis due to thyroid carcinoma. (D) T
loc  resection.
hich was completely resected. The patient underwent 131I abla-
ion therapy at a dose of 150 mCi  due to the conventional papillary
omponent. Appropriate incorporation of the radiopharmaceutical
as found in the thyroid bed and in the diseased lung. At the 6-
onth follow-up, the patient demonstrated parathyroid hormone
evels in the normal range and TSH suppression with 150 mg of
evothyroxine (Figs. 1 and 2).
. Case 2A  Mexican 74-year-old female who in March 2011 arrived at
ur institution due a 3-year evolution of increased volume in the
pper sternal region associated with pain. Upon initial physical
ig. 2. (A) 74 year old female patient with clinical evidence of sternal metastasis. (B) Ster
fter sternal resection with polypropylene mesh. (D) Clinical results after primary closureetastasis. (B) Seventh to ninth rib metastasis on the right side. (C) Peripheral lesion
yroidectomy and sternal en bloc resection. (E) Seventh to ninth rib metastasis en
examination, a lesion was found in the cervical region of the left
lobe of the thyroid (∼4 × 4 cm), along with an increase in volume
on the upper sternal manubrium (5 ×5 cm). Lymph nodes were pal-
pated bilaterally. During the initial evaluation, an ultrasound was
carried out and reported a thyroid lesion predominantly altering
the left morphology. A rounded hypoechoic image was  identiﬁed
in the right lobe with calciﬁed edges measuring 19 × 9 mm.  The
lesion was  heterogeneous with ill-deﬁned borders and reached
the superior mediastinum. Multiple bilateral lymphadenopathy
of indeterminate aspect at the right IIA cervical level measured
16 × 4 mm and at the left III cervical level measured 17 × 6 mm.
Bone scan was performed with report of metastatic bone pathol-
ogy of the ﬁrst right rib and sternal manubrium. The patient
nal en bloc resection with a rim resection of the clavicle. (C) Reconstruction defect
.
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Table  1
Patient information for reported cases of sternal thyroid cancer metastases.
Case No. Age (yr) Sex Size (cm) Diagnosis Symptoms Other metastases Year reported References
1 61 F 6 × 5 × 4.5 Follicular Pain None 2006 Eroglu et al.
2 35 F 7  ×7 Poorly differentiated/follicular
component
Pain None 2000 Mishra et al.
3  43 M 7 × 10 Follicular None Pulmonary/vertebral 2000 Mishra et al.
4 69  F 8 × 4.5 Papillary Pain None 2004 Haraguchi et al.
5  54 F 4 × 4 Follicular Pain Pulmonary 1995 Ozaki et al.
6  48 F 8 × 6 Papillary Pain None 1995 Ozaki et al.
7  59 F NR Follicular NR Left neck 2005 Meyer et al.
8 62 F NR Poorly  differentiated with
follicular  component
NR Three lymph nodes 2001 Kinoglou et al.
9  75 F 12 × 9 Follicular None None 1998 Muthuphei et al.
10  75 F 14 × 8 × 7 Poorly differentiated with
follicular  component
Pain Pulmonary 2008 Yanagawa et al.
11  35 F 4.5 × 4.5 × 3 Poorly differentiated (insular)
with  papillary component
Dysphagia Dyspnea Ribs Lungs 2011 Present case
12 74  F 8 × 5.1 × 4.5 Papillary Pain Three lymph nodes 2011 Present case
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Podiﬁed from Yanagawa et al. J Thorac Oncol. 2009;4:1022–5.
R,  not reported.
nderwent surgery, which involved total thyroidectomy, bilat-
ral modiﬁed radical neck dissection, partial sternectomy, partial
esection of the ﬁrst right rib, Marlex mesh reconstruction and
lacement of bilateral Slidex Pneumokit (bioMérieux). The patient
as discharged 4 days postoperatively without complications. Final
athology report was conventional-type papillary thyroid carci-
oma with solid areas, oxyphilic changes and squamous metaplasia
ith lymphovascular permeation and invasion to adipose tissue
nd striated muscle. Sternal resection demonstrated bone tissue
able 2
reatment information for reported cases of sternal thyroid cancer metastases.
Case No. Resection Reconstruction Margins Com
1 Partial sternectomy,
including manubrium and
attached portions of
bilateral  clavicles and
costal  cartilage
Gore-Tex soft-tissue patch,
bipedicled  pectoralis major
ﬂaps
NR  Non
2  Partial sternectomy,
medial 2 cm of clavicles,
ﬁrst and second ribs
Marlex mesh NR Non
3  Partial sternectomy,
anterior ﬁrst 3 ribs, medial
clavicles,  manubrium
Marlex mesh NR Non
4  Subtotal sternectomy Marlex mesh sandwiched
between  stainless steel
mesh
NR  Non
5  Total sternectomy Artiﬁcial sternum made of
methyl methacrylate
secured with metallic wires
NR Non
6  Subtotal sternectomy Methyl methacrylate
sandwiched between
Marlex  mesh
NR Non
7  Partial sternectomy Polypropylene mesh NR Non
8 Partial  sternectomy Marlex mesh, left pedicled
pectoralis  major muscle
ﬂap
Negative  Non
9  NR Prolene mesh NR Blee
10  Total sternectomy Methyl methacrylate
sandwiched between
layers  of polypropylene
mesh,  bipedicled pectoralis
major  muscle ﬂaps
Negative Non
11  Partial sternectomy,
resection of 3 ribs
Marlex mesh Negative Non
12  Partial sternectomy,
resection of 2 ribs
Marlex mesh Negative Non
odiﬁed from Yanagawa et al. J Thorac Oncol. 2009;4:1022–5.
artial sternectomy, <50% resection; subtotal sternectomy, >50% resection; total sternectwith  metastases from papillary thyroid carcinoma with invasion
to soft tissue and negative margins. Metastatic disease was found
in 3/60 nodes during neck dissection. Due to these ﬁndings, after
administration of Thyrogen (Genzyme) (thyrotropin alpha) at a
dose of 0.9 mg  IM on two consecutive days, the patient underwent
ablation with 131I (total of 150 mCi). Radiopharmaceutical tracer
was demonstrated in the thyroid bed. Currently the patient is under
suppression with levothyroxine at a dose of 150 g per day and is
asymptomatic.
plications Follow-up Recurrence Additional treatment
e 1 yr No RAI
e None Unknown None
e NR No RAI, resection of
vertebral  metastasis
e 3 mo No None
e 2.5 yr (death) Yes (pulmonary and
bony  metastases)
RAI
e 5mo No None
e 4.5 yr Yes (pulmonary
metastases, local
recurrence  in the neck)
RAI × 4
e 1 yr No External radiation
ding, sepsis 1 mo No None
e 2 yr Yes (unknown
location)
RAI  × 2
e 7 mo No RAI
e 2 mo No RAI
omy, 100% resection. NR, not reported; RAI, radioiodine.
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. Discussion
According to the series reviewed, patients with well-
ifferentiated thyroid cancer may  present with extracervical
etastasis in 5–10% of cases at diagnosis.4 Do et al.5 reported an
ncidence of bone metastases of 0.4% (13/3154) due to papillary
arcinoma. Management remains controversial. An increased fre-
uency of lung and bone disease has been reported in follicular
ariants because dissemination is predominantly hematogenous,
hich is less frequent in the papillary variant. Insular tumors of the
hyroid may  present with clinical and pathological features similar
o papillary carcinoma, e.g., a tendency to spread via the lymphatic
ystem, extrathyroidal invasion, lung metastases, and other fea-
ures of follicular carcinoma such as bone metastases and visceral
nvolvement.6
There are only isolated cases reported in the literature of the
ole surgery plays in the presence of single or multiple bulky bone
etastases (Table 1). The basis for initial surgical approach is keep-
ng in mind that the surgical procedure is palliative in order to
chieve optimal hypothetical ablation as a result of reduced tumor
olume. As reported in Case 1, the patient had disease in the lung,
ternum and ribs and resection was performed of the renal lesion
hich, at that time, was considered to be a metastasis and ulti-
ately was diagnosed as a primary tumor of the kidney.
During the 1990s, Ozaki et al.7 reported the ability to resect
etastatic lesions to the sternum in two patients with well-
ifferentiated thyroid cancer with a good evolution. Special
ttention was paid to sternal reconstruction using acrylic resin and
 polypropylene mesh. We  now believe that this procedure is obso-
ete because reconstruction with polypropylene mesh is sufﬁcient.
s shown in our cases and in cases where it is necessary to include
art of the skin, there is an option of reconstruction with free ﬂaps
fter placement of the mesh and an anastomosis to the internal
ammary artery8 (Table 2).
In a study by Pak et al.9 that reported the experience of resection
f metastatic lesions in non-medullary thyroid cancer, there were
4 patients reported with bone disease from a total of 47 sur-
eries performed. Although sternal disease was  not reported, it
as concluded that patients may  have a discrete improvement
n disease-free period or at least greater effectiveness toward the
dministration of iodine after metastasectomy. This is especially
rue when an adequate resection of bone lesions has been done in
he presence of lung metastases and where the use of 131I is opti-
ized for treatment of these pulmonary lesions where surgery has
 limited role, as reported here for Case 1.
Yanagawa et al.10, in a review of 10 patients presenting with
etastatic disease to the sternum, reported that all patients were
andidates for safe surgical resection and with adequate palliation,
s well as for the hypothetical potentiation of iodine therapy. In
ddition to the above, it prevented symptoms associated with these
esions such as pain, ulceration, and dyspnea, which occur at later
tages in these patients and affect their quality of life, as reported
y Kitamura et al.11 These authors observed that patients with
ternal disease may  present superior vena cava syndrome, with
onsequent circulatory arrest and immediate death. We  observed
hat, despite the poor prognosis of patients with metastatic bone
nd multiple lung disease, surgery can be performed safely and
ith adequate results in younger or older patients, as in our cases
eported here.
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In conclusion, sternal metastases and resection surgery, when
possible, allow for optimization of the dose of 131I. In the presence
of lung metastases, there is an important palliative role from the
standpoint of pain, which allows the patient to have a near-normal
quality of life because, after sternal resection, quality of life is not
altered.
Conﬂict of interest statement
None.
Funding
None.
Ethical  approval
None.
Author contributions
Kuauhyama Luna-Ortiz – study design, write manuscript; Rosa
A Salcedo Hernández – write manuscript; Leonardo Saul Lino-Silva
– review and write manuscript; Antonio Gómez-Pedraza – review
and write manuscript.
Acknowledgments
Due  to the retrospective nature of this study, it was granted an
exemption in writing by the Instituto Nacional de cancerología. We
state that are not plagiarism in our work.
References
1. Grubbs EG, Rich TA, Li G, Sturgis EM,  Younes MN,  Myers JN, et al. Recent advances
in thyroid cancer. Current Problems in Surgery 2008;45:156–250.
2. Luna-Ortiz K, Hurtado-López LM,  Domínguez-Malagón H, Ramírez-Marín R,
Zaldivar-Ramírez FR, Herrera-Gómez A, et al. Clinical course of insular thyroid
carcinoma. Medical Science Monitor 2004;10:108–11.
3. Hundahl SA, Fleming ID, Fremgen AM,  Menck HR. A National Cancer Data Base
report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995.
Cancer  1998;83:2638–48.
4. Harness JK, McLeod MK, Thompson NW,  Noble WC,  Burney RE. Deaths due to
differentiated thyroid cancer: a 46-year perspective. World Journal of Surgery
1998;12:623–9.
5. Do MY,  Rhee Y, Kim DJ, Kim CS, Nam KH, Ahn CW,  et al. Clinical features of bone
metastases resulting from thyroid cancer: a review of 28 patients over a 20-year
period. Endocrine Journal 2005;52:701–7.
6. Eroglu A, Karaoglanoglu N, Bilen H, Gursan N. Follicular thyroid carcinoma:
metastasis  to the sternum, 13 years after total thyroidectomy. International
Journal  of Clinical Practice 2006;60:1506–8.
7. Ozaki O, Kitagawa W,  Koshiishi H, Sugino K, Mimura T, Ito K.  Thyroid carcinoma
metastasized  to the sternum: resection of the sternum and reconstruction with
acrylic resin. Journal of Surgical Oncology 1995;60:282–5.
8.  Urken ML,  Higgins KM,  Lee B, Vickery C. Internal mammary artery and vein:
recipient vessels for free tissue transfer to the head and neck in the vessel-
depleted  neck. Head and Neck 2006;28:797–801.
9.  Pak H, Gourgiotis L, Chang WI,  Guthrie LC, Skarulis MC,  Reynolds JC, et al. Role of
metastasectomy in the management of thyroid carcinoma: the NIH experience.
Journal  of Surgical Oncology 2003;82:10–8.
0.  Yanagawa J, Abtin F, Lai CK, Yeh M, Britten CD, Martinez D, et al. Resection
of  thyroid cancer metastases to the sternum. Journal of Thoracic Oncology
2009;4:1022–5.
1.  Kitamura Y, Shimizu K, Nagahama M,  Sugino K, Ozaki O, Mimura T, et al. Imme-
diate causes of death in thyroid carcinoma: clinicopathological analysis of 161
fatal cases. Journal of Clinical Endocrinology and Metabolism 1999;84:4043–9.
